Vascular Solutions, Inc. (VASC) Tops Q1 EPS by 1c; Guides for Q2 and FY
Get Alerts VASC Hot Sheet
Price: $56.00 --0%
Financial Fact:
Income tax expense: -1.82M
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Income tax expense: -1.82M
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Vascular Solutions, Inc. (NASDAQ: VASC) reported Q1 EPS of $0.12, $0.01 better than the analyst estimate of $0.11. Revenue for the quarter came in at $23.8 million versus the consensus estimate of $22.51 million.
Vascular Solutions, Inc. sees Q2 2012 EPS of $0.13-$0.15, versus the consensus of $0.13. Vascular Solutions, Inc. sees Q2 2012 revenue of $24.1-$24.5 million, versus the consensus of $23.7 million.
Vascular Solutions, Inc. sees FY2012 EPS of $0.53-$0.57, versus prior guidance of $0.51-$0.55 and the consensus of $0.54. Vascular Solutions, Inc. sees FY2012 revenue of $96-$98 million, versus the consensus of $95.3 million.
For earnings history and earnings-related data on Vascular Solutions, Inc. (VASC) click here.
Vascular Solutions, Inc. sees Q2 2012 EPS of $0.13-$0.15, versus the consensus of $0.13. Vascular Solutions, Inc. sees Q2 2012 revenue of $24.1-$24.5 million, versus the consensus of $23.7 million.
Vascular Solutions, Inc. sees FY2012 EPS of $0.53-$0.57, versus prior guidance of $0.51-$0.55 and the consensus of $0.54. Vascular Solutions, Inc. sees FY2012 revenue of $96-$98 million, versus the consensus of $95.3 million.
For earnings history and earnings-related data on Vascular Solutions, Inc. (VASC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- AMC Networks (AMCX) PT Raised to $10 at UBS on Higher Cash Generation, Visibility
- Abercrombie & Fitch (ANF) PT Raised to $153 at UBS on Decent Q2, Stable Trend Across Brands
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share